Bv8 nucleic acids and polypeptides with mitogenic activity

Details Bv8 nucleic acids and polypeptides with mitogenic activity Bv8 nucleic acids and polypeptides with mitogenic activity

2006-06-13

2006-06-13

Nickol, Gary B. (Department: 1642)

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

C435S004000, C530S350000, C514S002600

Reexamination Certificate

active

07060278

ABSTRACT:
The present invention provides methods of using Bv8 polypeptides to induce endothelial cell proliferation and to enhance endothelial cell survival. Also provided herein are methods of screening for modulators of Bv8 activity. Furthermore, methods of treatment using Bv8 polypeptides are provided.

REFERENCES:
patent: 4109496 (1978-08-01), Allemann et al.
patent: 4419446 (1983-12-01), Howley et al.
patent: 4601978 (1986-07-01), Karin
patent: 5010182 (1991-04-01), Brake et al.
patent: 5240848 (1993-08-01), Keck et al.
patent: 5332671 (1994-07-01), Ferrara et al.
patent: 5364934 (1994-11-01), Drayna et al.
patent: 5561053 (1996-10-01), Crowley
patent: 5605793 (1997-02-01), Stemmer
patent: 5837458 (1998-11-01), Minshull et al.
patent: 2002/0172678 (2002-11-01), Ferrara et al.
patent: 0 307 247 (1989-03-01), None
patent: 0 362 179 (1990-04-01), None
patent: WO 90/13646 (1990-11-01), None
patent: WO 91/08291 (1991-06-01), None
patent: WO 91/08298 (1991-06-01), None
patent: WO 98/10071 (1998-03-01), None
patent: WO 01/36465 (2001-05-01), None
patent: WO 02/36625 (2002-05-01), None
Burgess et al., J of Cell Bio. 111:2129-2138, 1990.
Lazar et al. Molecular and Cellular Biology 8:1247-1252, 1988.
Bowie et al. Science, 247:1306-1310, 1990.
LeCouter et al. (Proc.Natl.Acad.Sci., 2003, vol. 100, No. 5, Abstract).
Aird, W. et al., “Vascular Bed-specific Expression of an Endothelial Cell Gene is Programmed by the Tissue Microenvironment,”The Journal of Cell Biology, vol. 138, No. 5, pp. 1117-1124 (Sep. 8, 1997).
Aravind, L. et al., “A colipase fold in the carboxy-terminal dormain of the Wnt antagonists—the Dickkopfs.”Current Biology, vol. 8, No. 14, pp. R477-R478 (1998).
Aruffo, A. et al., “CD44 is the Principal Cell Surface Receptor for Hyaluronate,”Cell, vol. 61. pp. 1303-1313 (Jun. 29, 1990).
Ashkenazi, A. et al., “Immunoadhesins,”Intern. Rev. Immunol., vol. 10, pp. 219-227 (1993).
Ashkenazi, A. et al., “Protection against endotoxic shock by a tumor necrosis factor receptor immunoadhesin,”Proc. Natl. Acad. Sci. USA, vol. 88, pp. 10535-10539 (Dec. 1991).
Bianchi, M. et al., “Transformation of the yeastKluyveromyces lactisby new vectors derived from the 1.6 μm circular plasmid pKD1,”Curr. Genet., vol. 12, pp. 185-192 (1987).
Carmeliet, P., “Mechanisms of angiogenesis and arteriogenesis,”Nature Medicine, vol. 6, No. 3, pp. 389-395 (Mar. 2000).
Carter, P. et al., “Improved oligonucleotide site-directed mutagenesis using M13 vectors,”Nucleic Acids Research, vol. 13, No. 12, pp. 4431-4443 (1985).
Carter, P. et al., “High LevelEscherichia coliExpression and Production of a Bivalent Humanized Antibody Fragment,”Bio/Technology, vol. 10, pp. 163-167 (Feb. 1992).
Chothia, C. et al., “Canonical Structures for the Hypervariable Regions of Immunoglobulins,”J. Mol. Biol., vol. 196, pp. 901-917 (1987).
Cunningham, B. et al., “High-Resolution Epitope Mapping of hGH-Receptor Interactions by Alanine-Scanning Mutagenesis,”Science, vol. 244, pp. 1081-1085 (Jun. 2, 1989).
Dellian, M. et al., “Quantitation and Physiological Characterization of Angiogenic Vessels in Mice,”Amer. Journal of Pathology, vol. 149, No. 1, pp. 59-71 (Jul. 1996).
Dietsch, M. et al., “Bispecific receptor globulins, novel tools for the study of cellular interactions,”Journal of Immunological Methods, vol. 162, pp. 123-132 (1993).
Dzau, V et al., “Gene therapy for cardiovascular disease,”Trends Biotechnol., vol. 11, pp. 205-210 (1993).
Ferrara, N. et al., “Clinical applications of angiogenic growth factors and their inhibitors,”Nature Medicine, vol. 5, No. 12, pp. 1359-1364 (Dec. 1999).
Fleer, R. et al., “Stable Multicopy Vectors for High-Level Secretion of Recombinant Human Serum Albumin byKluyveromycesYeasts,”Bio/Technology, vol. 9, pp. 968-975 (Oct. 1991).
Gascoigne, N et al., “Secretion of a chimeric T-cell receptor-immunoglobulin protein,”PNAS USA, vol. 84, pp. 2936-2940 (May 1987).
Gautier et al., “DNA IV: α-anomeric and β-anomeric tetrathymidylates covalently linked to intercalating oxazolopyridocarbazole. Synthesis, physicochemical properties and poly (rA) binding,”Nucleic Acids Research, vol. 15, No. 16, pp. 6625-6641 (1987).
Hoogenboom, H. et al., “Construction and Expression of Antibody-Tumor Necrosis Factor Fusion Proteins,”Molecular Immunology, vol. 28, No. 9, pp. 1027-1037 (1991).
Houghten, R. et al., “Generation and use of synthetic peptide combinatorial libraries for basic research and drug discovery,”Nature, vol. 354, pp. 84-86 (Nov. 7, 1991).
Inoue, H. et al., “Sequence-dependent hydrolysis of RNA using modified oligonucleotide splints and RNase H,”FEBS Letters, vol. 215, No. 2, pp. 327-330 (May 1987).
Inoue, H. et al., “Synthesis and hybridization studies on two complementary nona(2′-O-methyl)ribonucleotides,”Nucleic Acids Research, vol. 15, No. 15, pp. 6131-6148 (1987).
Keck, P. et al., “Vascular Permeability Factor, an Endothelial Cell Mitogen Related to PDGF,”Science, vol. 246, pp. 1309-1312 (Dec. 8, 1989).
Lam, K. et al., “A new type of synthetic peptide library for identifying ligand-binding activity,”Nature, vol. 354, pp. 82-84 (Nov. 7, 1991).
LeCouter, J. et al., “Identification of an angiogenic mitogen selective for endocrine gland endothelium,”Nature, vol. 412, pp. 877-884 (Aug. 30, 2001).
Leung, D. et al., “Vascular Endothelial Growth Factor is a Secreted Angiogenic Mitogen,”Science, vol. 246, pp. 1306-1309 (Dec. 8, 1989).
Li, M. et al., “Identification of Two Prokineticin cDNAs: Recombinant Proteins Potently Contract Gastrointestinal Smooth Muscle,”Molecular Pharm., vol. 59, No. 4, pp. 692-698 (2001).
Lovell, D. et al., “Etanercept in Children with Polyarticular Juvenile Rheumatoid Arthritis,”The New England Journal of Medicine, vol. 342, No. 11, pp. 763-769 (Mar. 16, 2000).
Maini, R. et al., “Anti-Cytokine Therapy for Rheumatoid Arthritis,”Annu. Rev. Med., vol. 51, pp. 207-229 (2000).
Martin, S. et al., “Efficient Neutralization and Disruption of Rhinovirus by Chimeric ICAM-1/Immunoglobulin Molecules,”Journal of Virology, vol. 67, No. 6, pp. 3561-3568 (Jun. 1993).
Mollay, C. et al., “Bv8, a small protein from frog skin and its homologue from snake venom induce hyperalgesia in rats,”European Journal of Pharmacology, vol. 374, pp. 189-196 (1999).
Platt, K. et al., “Independent Regulation of Adipose Tissue-specificity and Obesity Response of the Adipsin Promoter in Transgenic Mice,”The Journal of Biological Chemistry, vol. 269, No. 46, pp. 28558-28562 (Nov. 18, 1994).
Roberts, W. et al., “Host Microvasculature Influence on Tumor Vascular Morphology and Endothelial Gene Expression,”Amer. Journal of Pathology, vol. 153, No. 4, pp. 1239-1248 (Oct. 1998).
Schweitz, H. et al., “MIT1, a black mamba toxin with a new and highly potent activity on intestinal contraction,”FEBS Letters, vol. 461, pp. 183-188 (1999).
Siebenlist, U. et al., “E. coli RNA Polymerase Interacts Homologously with Two Different Promoters,”Cell, vol. 20, pp. 269-281 (Jun. 1980).
Simionescu, N. et al., “The Cardiovascular System,”Cell and Tissue Biology—A Textbook of History, Sixth Edition, Chapter 10, pp. 355-400 (1988).
Songyang, Z. et al., “SH2 Domains Recognize Specific Phosphopeptide Sequences,”Cell, vol. 72, pp. 767-778 (Mar. 12, 1993).
Stamenkovic, I. et al., “The B Lymphocyte Adhesion Molecule CD22 Interacts with Leukocyte Common Antigen CD45RO on T Cells and α2-6 Sialyltransferase, CD75, on B Cells,”Cell, vol. 66, pp. 1133-1144 (Sep. 20, 1991).
Stewart, P. et al., “Developing Nervous Tissue Induces Formation of Blood-Brain Barrier Characteristics in Invading Endothelial

Affiliated with

Also associated with

Rating

Bv8 nucleic acids and polypeptides with mitogenic activity does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Bv8 nucleic acids and polypeptides with mitogenic activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bv8 nucleic acids and polypeptides with mitogenic activity will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3696015